METASTATIC BLADDER CARCINOMA
Clinical trials for METASTATIC BLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC BLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple-Drug attack shows promise for rare bladder and kidney cancers
Disease control Recruiting nowThis study tests a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—in people with rare genitourinary cancers that have spread. The goal is to see if this mix can shrink tumors or stop them from growing. About 314 adults with these rare cancers will take part. T…
Matched conditions: METASTATIC BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 06:50 UTC
-
New study tests whether a simple support tool can empower bladder cancer patients
Knowledge-focused Recruiting nowThis study looks at whether an education and navigation support tool can help patients with advanced bladder cancer and their caregivers take a more active role in treatment decisions. The program is designed for older adults who often have other health issues and limited access …
Matched conditions: METASTATIC BLADDER CARCINOMA
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated May 17, 2026 06:46 UTC